State Street’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,763,828
Closed -$267M 5008
2022
Q3
$267M Buy
1,763,828
+18,782
+1% +$2.84M 0.02% 634
2022
Q2
$254M Buy
1,745,046
+89,212
+5% +$13M 0.02% 656
2022
Q1
$196M Buy
1,655,834
+8,140
+0.5% +$965K 0.01% 844
2021
Q4
$227M Buy
1,647,694
+162,764
+11% +$22.4M 0.01% 795
2021
Q3
$206M Buy
1,484,930
+4,363
+0.3% +$606K 0.01% 820
2021
Q2
$144M Sell
1,480,567
-54,177
-4% -$5.26M 0.01% 1045
2021
Q1
$105M Sell
1,534,744
-137,205
-8% -$9.38M 0.01% 1197
2020
Q4
$143M Sell
1,671,949
-101,223
-6% -$8.68M 0.01% 909
2020
Q3
$115M Buy
1,773,172
+2,463
+0.1% +$160K 0.01% 891
2020
Q2
$129M Sell
1,770,709
-205,232
-10% -$15M 0.01% 822
2020
Q1
$67.2M Buy
1,975,941
+64,533
+3% +$2.2M 0.01% 1067
2019
Q4
$104M Sell
1,911,408
-133,535
-7% -$7.27M 0.01% 1024
2019
Q3
$85.3M Buy
2,044,943
+456,986
+29% +$19.1M 0.01% 1101
2019
Q2
$69.5M Buy
1,587,957
+248,909
+19% +$10.9M 0.01% 1265
2019
Q1
$68.9M Buy
1,339,048
+327,534
+32% +$16.9M 0.01% 1258
2018
Q4
$37.4M Sell
1,011,514
-310,841
-24% -$11.5M ﹤0.01% 1542
2018
Q3
$49.7M Sell
1,322,355
-168,597
-11% -$6.33M ﹤0.01% 1541
2018
Q2
$58.9M Buy
1,490,952
+982,149
+193% +$38.8M ﹤0.01% 1378
2018
Q1
$13.1M Buy
508,803
+329,986
+185% +$8.5M ﹤0.01% 2332
2017
Q4
$4.82M Buy
178,817
+18,042
+11% +$487K ﹤0.01% 2810
2017
Q3
$6.01M Buy
160,775
+43,563
+37% +$1.63M ﹤0.01% 2703
2017
Q2
$2.93M Buy
+117,212
New +$2.93M ﹤0.01% 2979